Cargando…

Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study

Research is lacking on the reversibility of antimicrobial resistance (AMR). Thus, we aimed to determine the influence of previous antibiotic use on the development and decay over time of third generation cephalosporin (3GC)-resistance of E. coli. Using the database of hospital laboratories of the Au...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulgenzio, Chiara, Massari, Marco, Traversa, Giuseppe, Da Cas, Roberto, Ferrante, Gianluigi, Aschbacher, Richard, Moser, Verena, Pagani, Elisabetta, Vestri, Anna Rita, Massidda, Orietta, Kurotschka, Peter Konstantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073604/
https://www.ncbi.nlm.nih.gov/pubmed/33923682
http://dx.doi.org/10.3390/antibiotics10040451
_version_ 1783684168227487744
author Fulgenzio, Chiara
Massari, Marco
Traversa, Giuseppe
Da Cas, Roberto
Ferrante, Gianluigi
Aschbacher, Richard
Moser, Verena
Pagani, Elisabetta
Vestri, Anna Rita
Massidda, Orietta
Kurotschka, Peter Konstantin
author_facet Fulgenzio, Chiara
Massari, Marco
Traversa, Giuseppe
Da Cas, Roberto
Ferrante, Gianluigi
Aschbacher, Richard
Moser, Verena
Pagani, Elisabetta
Vestri, Anna Rita
Massidda, Orietta
Kurotschka, Peter Konstantin
author_sort Fulgenzio, Chiara
collection PubMed
description Research is lacking on the reversibility of antimicrobial resistance (AMR). Thus, we aimed to determine the influence of previous antibiotic use on the development and decay over time of third generation cephalosporin (3GC)-resistance of E. coli. Using the database of hospital laboratories of the Autonomous Province of Bolzano/Bozen (Italy), anonymously linked to the database of outpatient pharmaceutical prescriptions and the hospital discharge record database, this matched case-control study was conducted including as cases all those who have had a positive culture from any site for 3GC resistant E. coli (3GCREC) during a 2016 hospital stay. Data were analyzed by conditional logistic regression. 244 cases were matched to 1553 controls by the date of the first isolate. Male sex (OR 1.49, 95% CI 1.10–2.01), older age (OR 1.11, 95% CI 1.02–1.21), the number of different antibiotics taken in the previous five years (OR 1.20, 95% CI 1.08–1.33), at least one antibiotic prescription in the previous year (OR 1.92, 95% CI 1.36–2.71), and the diagnosis of diabetes (OR 1.57, 95% CI 1.08–2.30) were independent risk factors for 3GCREC colonization/infection. Patients who last received an antibiotic prescription two years or three to five years before hospitalization showed non-significant differences with controls (OR 0.97, 95% CI 0.68–1.38 and OR 0.85, 95% CI 0.59–1.24), compared to an OR of 1.92 (95% CI 1.36–2.71) in those receiving antibiotics in the year preceding hospitalization. The effect of previous antibiotic use on 3GC-resistance of E. coli is highest after greater cumulative exposure to any antibiotic as well as to 3GCs and in the first 12 months after antibiotics are taken and then decreases progressively.
format Online
Article
Text
id pubmed-8073604
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80736042021-04-27 Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study Fulgenzio, Chiara Massari, Marco Traversa, Giuseppe Da Cas, Roberto Ferrante, Gianluigi Aschbacher, Richard Moser, Verena Pagani, Elisabetta Vestri, Anna Rita Massidda, Orietta Kurotschka, Peter Konstantin Antibiotics (Basel) Article Research is lacking on the reversibility of antimicrobial resistance (AMR). Thus, we aimed to determine the influence of previous antibiotic use on the development and decay over time of third generation cephalosporin (3GC)-resistance of E. coli. Using the database of hospital laboratories of the Autonomous Province of Bolzano/Bozen (Italy), anonymously linked to the database of outpatient pharmaceutical prescriptions and the hospital discharge record database, this matched case-control study was conducted including as cases all those who have had a positive culture from any site for 3GC resistant E. coli (3GCREC) during a 2016 hospital stay. Data were analyzed by conditional logistic regression. 244 cases were matched to 1553 controls by the date of the first isolate. Male sex (OR 1.49, 95% CI 1.10–2.01), older age (OR 1.11, 95% CI 1.02–1.21), the number of different antibiotics taken in the previous five years (OR 1.20, 95% CI 1.08–1.33), at least one antibiotic prescription in the previous year (OR 1.92, 95% CI 1.36–2.71), and the diagnosis of diabetes (OR 1.57, 95% CI 1.08–2.30) were independent risk factors for 3GCREC colonization/infection. Patients who last received an antibiotic prescription two years or three to five years before hospitalization showed non-significant differences with controls (OR 0.97, 95% CI 0.68–1.38 and OR 0.85, 95% CI 0.59–1.24), compared to an OR of 1.92 (95% CI 1.36–2.71) in those receiving antibiotics in the year preceding hospitalization. The effect of previous antibiotic use on 3GC-resistance of E. coli is highest after greater cumulative exposure to any antibiotic as well as to 3GCs and in the first 12 months after antibiotics are taken and then decreases progressively. MDPI 2021-04-16 /pmc/articles/PMC8073604/ /pubmed/33923682 http://dx.doi.org/10.3390/antibiotics10040451 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fulgenzio, Chiara
Massari, Marco
Traversa, Giuseppe
Da Cas, Roberto
Ferrante, Gianluigi
Aschbacher, Richard
Moser, Verena
Pagani, Elisabetta
Vestri, Anna Rita
Massidda, Orietta
Kurotschka, Peter Konstantin
Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study
title Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study
title_full Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study
title_fullStr Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study
title_full_unstemmed Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study
title_short Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study
title_sort impact of prior antibiotic use in primary care on escherichia coli resistance to third generation cephalosporins: a case-control study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073604/
https://www.ncbi.nlm.nih.gov/pubmed/33923682
http://dx.doi.org/10.3390/antibiotics10040451
work_keys_str_mv AT fulgenziochiara impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT massarimarco impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT traversagiuseppe impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT dacasroberto impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT ferrantegianluigi impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT aschbacherrichard impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT moserverena impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT paganielisabetta impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT vestriannarita impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT massiddaorietta impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy
AT kurotschkapeterkonstantin impactofpriorantibioticuseinprimarycareonescherichiacoliresistancetothirdgenerationcephalosporinsacasecontrolstudy